Researchers in Korea generated a new method for generating CHO cell lines with significantly higher productivity, efficiency, ...

The U.K. Centre for Process Innovation (CPI), says a new blueprint will help biopharmaceutical firms navigate a digital ...

Although biologics are usually given by injection or intravenous infusion, oral formulations might be possible.

The researchers now plan to incorporate their new tool into a drug development program, leading to early clinical trials.

Trained on data covering 1.5 billion years of evolution, CZI’s new generative AI model probes cellular biology across species for therapeutic applications.

A potential strategy introduces an entirely new type of therapy capable of addressing previously ‘undruggable’ targets within ...

Merck KGaA said the deal will grow its U.S. presence and expand the reach of SpringWorks’ drugs, including one approved in February.

AML patients in the trial who were treated with SENTI-202 experienced complete remission after not responding to prior ...

Johanna Joyce, PhD, then took the rostrum and spoke eloquently on the tumor microenvironment, underscoring the immense ...

Integrating a cell line development capability into Cytiva’s biomanufacturing technologies could enhance a customer's ...

LUT014 works by paradoxically reactivating MAPK, a key signaling pathway in the skin that anti-EGFR therapies shut down.

Velsera and Complete Genomics are expanding their ability to serve clinical labs with an end-to-end solution from sample to ...